ANTIARRHYTHMIC DRUG DOSING METHODS, MEDICAL DEVICES, AND SYSTEMS

Patent №

US 11,610,660

Granted

2023-03-21

Filed 2021

Owner

ALTATHERA PHARMACEUTICALS LLC

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

17566840

The disclosure relates to a method which includes i) prompting input of: a creatinine clearance (CrCl) of a subject; whether the subject is being initiated or escalated on sotalol hydrochloride; an amount of an oral target dosage of sotalol hydrochloride for the subject; and optionally a projected start time for sotalol hydrochloride infusion; and ii) executing computer executable instructions to derive from a set of rules a sotalol hydrochloride dosing protocol for the subject based on the inputs. The disclosure also relates to systems and medical devices configured to perform one or more steps of the method, as well as a non-transitory computer-readable storage medium comprising computer-executable instructions or software stored thereon capable of performing one or more steps of the method.

PlanningG16H 20/17A61K 31/18A61M 5/172G16H 20/10G16H 40/63G16H 50/20

AI classification

Planning0.57
AI hardware0.41
Natural language0.08
Knowledge representation0.02
Vision0.01
Machine learning0.00
Evolutionary computation0.00
Speech0.00

Ownership

ALTATHERA PHARMACEUTICALS LLC

assignment · 602480297

Assignors

DEVLIN, JODI

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC